Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BREO ELLIPTA vs BREXPIPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BREO ELLIPTA vs BREXPIPRAZOLE: Safety Overview

Metric BREO ELLIPTA BREXPIPRAZOLE
Total FAERS Reports 218 13,270
Deaths Reported 1 673
Death Rate 0.5% 5.1%
Hospitalizations 20 1,269
Average Patient Age 70.0 yrs 50.5 yrs
% Female Patients N/A 69.0%
FDA Approval Date N/A Aug 11, 2022
Manufacturer N/A Otsuka America Pharmaceutical, Inc.
Route N/A ORAL
Marketing Status N/A Prescription